Skip to main content

Peer Review reports

From: Transarterial chemoembolization with molecular targeted therapies plus camrelizumab for recurrent hepatocellular carcinoma

Original Submission
4 Feb 2024 Submitted Original manuscript
29 Feb 2024 Reviewed Reviewer Report
10 Mar 2024 Author responded Author comments - Changlong Hou
15 Mar 2024 Author responded Author comments - Changlong Hou
Resubmission - Version 2
10 Mar 2024 Submitted Manuscript version 2
Publishing
19 Mar 2024 Editorially accepted
27 Mar 2024 Article published 10.1186/s12885-024-12144-6

You can find further information about peer review here.

Back to article page